In a study published in September in the journal iScience, metformin was found to have potential benefits for people living with HIV. In a 12-week pilot clinical trial involving 13 participants on antiretroviral therapy, metformin supplementation helped boost the immune system’s ability to target and contain the virus.
In a separate study, published Sept. 17 in Diabetes Care suggests metformin use before and during a COVID-19 infection can reduce the risk of severe COVID and post-acute sequelae of COVID-19. In the cohort analysis, metformin users with Type 2 diabetes saw a 21% lower risk of death or PASC compared to those using other diabetes medications.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
